Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.6× sales vs its 6.0× historical median P/S.
Fair value ≈ $70.69 · price $7.00 today
Undervalued · 90% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$DVHGF [15s. delayed]: Issued Press Release on June 20, 08:45:00: Groupe Santé Devonian reçoit un avis d'autorisation de délivrance d https://s.flashalert.me/nZg5v
$DVHGF [15s. delayed]: Issued Press Release on June 20, 08:45:00: Devonian Health Group Receives a Notice of Allowance for Issuance of a U https://s.flashalert.me/ZN1H5F
$DVHGF Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.
https://www.stocktitan.net/news/DVHGF/devonian-health-group-receives-a-notice-of-allowance-for-issuance-of-4mgluw2o9vxz.html
#patent
$DVHGF Devonian Announces Closing of a Private Placement of $1.2 Million
https://www.stocktitan.net/news/DVHGF/devonian-announces-closing-of-a-private-placement-of-1-2-g86opahtf7n7.html
$DVHGF Devonian Announces Private Placement of up to $5 Million
https://www.stocktitan.net/news/DVHGF/devonian-announces-private-placement-of-up-to-5-usab7uqocchb.html
$DVHGF [15s. delayed]: Issued Press Release on May 16, 08:45:00: Groupe Santé Devonian annonce la présentation des résultats d’efficacité https://s.flashalert.me/gE3ko
$DVHGF [15s. delayed]: Issued Press Release on May 16, 08:45:00: Devonian Health Group Announces Presentation of Thykamine™ Efficacy Resul https://s.flashalert.me/66ol3
$DVHGF Devonian Health Group Announces Presentation of Thykamine™ Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine™ Clinical Development Program Update.
https://www.stocktitan.net/news/DVHGF/devonian-health-group-announces-presentation-of-thykamine-efficacy-id3fh3hf2p2a.html
$DVHGF Devonian Announces Filing of Preliminary Base Shelf Prospectus
https://www.stocktitan.net/news/DVHGF/devonian-announces-filing-of-preliminary-base-shelf-m8sc3l4ggk3w.html
$DVHGF [15s. delayed]: Issued Press Release on March 30, 16:00:00: Devonian annonce l’approbation de modifications à son régime d’options https://s.flashalert.me/02Fkn
$DVHGF [15s. delayed]: Issued Press Release on March 30, 16:00:00: Devonian Announces Approval of Amendments to its Stock Option Plan and https://s.flashalert.me/5K9eD9
$DVHGF Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan
https://www.stocktitan.net/news/DVHGF/devonian-announces-approval-of-amendments-to-its-stock-option-plan-oct68943whqj.html
$DVHGF [15s. delayed]: Issued Press Release on March 24, 16:00:00: Groupe Santé Devonian annonce les résultats de l’Assemblée Générale Ann https://s.flashalert.me/R78fB
$DVHGF [15s. delayed]: Issued Press Release on March 24, 16:00:00: Devonian Health Group Announces voting results of the Annual General an https://s.flashalert.me/maimqI
